Welcome to the Clara Nahmias’ lab Homepage


Clara Nahmias team is interested in studying cell-cell communication in normal and pathological situations, with a particular focus on the role of the angiotensin/ATIP axis and the microtubule cytoskeleton in breast cancer.

Seminal work of the team identified a novel family of proteins (ATIPs) initially isolated as interacting partners of the AT2 receptor. Recent studies led to the discovery that ATIP3 is a new anti-cancer molecule and a promising target for personalized therapies of aggressive breast cancer.


Clara Nahmias was awarded the ‘Prix du Ruban Rose Avenir’ in 2010 for these studies.

 This studies were recently highlighted in the Inserm Website:

"Breast Cancer: a protein prevents metastasis" > Read

Scientific news > Read

Projects of the team are supported by grants from the CNRS, Inserm, Gustave Roussy Institute, Roche laboratories, the Ligue Contre le Cancer, the association Le cancer du sein, parlons-en !, the fondation RAJA-Marcovici, the association Odyssea and the association Prolific.


Clara Nahmias Interview


Presentation of the ATIP3 project by Clara Nahmias



Recent publications






The ATIP3 project is mainly supported by the Ambassadeurs Odyssea  program.